LFSC holdings — F/m Emerald Life Sciences Innovation ETF
F/m Emerald Life Sciences Innovation ETF (LFSC) held 40 positions with net assets of $105M as of May 31, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 54.7% of the fund, led by TVTX, COGT, LIVN.
LFSC top holdings
- TVTX Travere Therapeutics Inc — 7.67% ($8.05M)
- COGT Cogent Biosciences Inc — 7.53% ($7.91M)
- LIVN LivaNova PLC — 7.11% ($7.47M)
- SYRE Spyre Therapeutics Inc — 6.41% ($6.73M)
- GH Guardant Health Inc — 5.52% ($5.80M)
- MIRM Mirum Pharmaceuticals Inc — 4.92% ($5.17M)
- CORT Corcept Therapeutics Inc — 4.79% ($5.03M)
- UTHR United Therapeutics Corp — 4.16% ($4.37M)
- MANE VeraDermics Inc — 3.42% ($3.59M)
- SVRA Savara Inc — 3.22% ($3.39M)
- CYTK Cytokinetics Inc — 3.16% ($3.32M)
- NKTR Nektar Therapeutics — 3.14% ($3.30M)
- TRVI Trevi Therapeutics Inc — 3.12% ($3.27M)
- DNTH Dianthus Therapeutics Inc — 3.09% ($3.24M)
- AXSM Axsome Therapeutics Inc — 2.84% ($2.98M)
- BLLN Billiontoone Inc — 2.73% ($2.87M)
- TMDX TransMedics Group Inc — 2.68% ($2.82M)
- VRDN Viridian Therapeutics Inc — 2.23% ($2.35M)
- ICUI ICU Medical Inc — 2.09% ($2.20M)
- CRVS Corvus Pharmaceuticals Inc — 1.95% ($2.05M)
- PVLA Palvella Therapeutics Inc — 1.95% ($2.04M)
- CBLL Ceribell Inc — 1.55% ($1.63M)
- GMED Globus Medical Inc — 1.27% ($1.33M)
- XERS Xeris Biopharma Holdings Inc — 1.22% ($1.28M)
- BBIO Bridgebio Pharma Inc — 1.17% ($1.23M)
What are LFSC's top 10 holdings?
TVTX (7.7%), COGT (7.5%), LIVN (7.1%), SYRE (6.4%), GH (5.5%), MIRM (4.9%), CORT (4.8%), UTHR (4.2%), MANE (3.4%), SVRA (3.2%).
How many stocks are in LFSC?
F/m Emerald Life Sciences Innovation ETF reported 40 holdings as of May 31, 2026.